LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-10
Case ID: NM_006231.4_c.2964G_T_20260810_144340
Framework: ACMG/AMP 2015 with custom gene-specific criterion specifications
Variant classification summary

NM_006231.4:c.2964G>T

POLE  · NP_006222.2:p.(Ser988=)  · NM_006231.4
GRCh37: chr12:133237651 C>A  ·  GRCh38: chr12:132661065 C>A
Gene: POLE Transcript: NM_006231.4
Final call
VUS
PM2 supporting BP7 supporting
All criteria require review: For research and educational purposes only.
Gene
POLE
Transcript
NM_006231.4
Protein
NP_006222.2:p.(Ser988=)
gnomAD AF
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada — no carriers in large control populations.
2
BP7 (Supporting): synonymous p.Ser988= with SpliceAI max delta 0.01, predicting no splice impact.
3
Overall: VUS — the conflicting PM2 and BP7 supporting evidence satisfies no enumerated Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination.
Final determination: The only met criteria are PM2 (supporting, pathogenic direction) and BP7 (supporting, benign direction), which conflict, and no enumerated ACMG/AMP 2015 Pathogenic/Likely Pathogenic/Benign/Likely Benign combination is satisfied, so the framework combination rule classifies this as Uncertain Significance (VUS).
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.2964G>T is synonymous (p.Ser988=) with no predicted splice impact, so it is not a null variant (SpliceAI max delta 0.01).
pvs1_variant_assessment pvs1_generic_framework pvs1_gene_context spliceai generic_acmg_combination_rules final_classification_framework
PS1 N/A Not applicable: the variant is synonymous (p.Ser988=), so no amino acid change exists to match a known pathogenic change.
pvs1_variant_assessment pm5_candidates vcep_path_250_323 PMID:25394175
PS2 Not assessed Not assessed: no de novo occurrence with confirmed parental testing is documented in ClinVar or the literature.
clinvar PMID:25394175 generic_acmg_combination_rules final_classification_framework
PS3 Not assessed Not assessed: no functional assay of this variant exists; the only related data is an in silico SpliceAI prediction (max delta 0.01), not a functional study.
PMID:25394175 vcep_path_250_323 spliceai generic_acmg_combination_rules
PS4 Not met Not met: the gene-specific rule applies only to recurrent missense variants (none at residue 988), and no case-control study exists for this variant.
final_classification_framework vcep_path_250_323_s002 clinvar PMID:25394175
PM1 N/A Not applicable: p.Ser988= is synonymous and lies outside the exonuclease domain (residues ~268-471) where all framework hotspots reside.
vcep_path_250_323 vcep_path_250_323_s002 pvs1_variant_assessment PMID:25394175
PM2 Met Met (supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada, satisfying the 'absent in controls' population criterion.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
PM3 Not assessed Not assessed: no proband genotype or phase data exist to evaluate a trans configuration with a pathogenic variant.
clinvar pm5_candidates generic_acmg_combination_rules final_classification_framework PMID:25394175
PM4 N/A Not applicable: a synonymous single-nucleotide substitution changes no amino acid and introduces no in-frame indel.
generic_acmg_combination_rules final_classification_framework
PM5 N/A Not applicable: the variant is synonymous (p.Ser988=), so there is no missense change to compare against a known pathogenic change.
pm5_candidates pvs1_variant_assessment vcep_path_250_323 PMID:25394175
PM6 Not assessed Not assessed: no de novo occurrence, with or without parentage confirmation, is documented for this variant.
clinvar PMID:25394175 generic_acmg_combination_rules final_classification_framework
PP1 Not assessed Not assessed: no segregation study or family testing data exists — zero informative meioses are documented.
clinvar PMID:25394175 generic_acmg_combination_rules final_classification_framework
PP2 N/A Not applicable: PP2 applies to missense variants, and this variant is synonymous (p.Ser988=).
pvs1_variant_assessment vcep_path_250_323 PMID:25394175
PP3 Not met Not met: SpliceAI predicts no splice impact (max delta 0.01), the only predictor available, so no computational evidence supports a deleterious effect.
spliceai vcep_path_250_323_s003 vcep_path_250_323_s004 final_classification_framework generic_acmg_combination_rules pvs1_variant_assessment
PP4 Not assessed Not assessed: no proband phenotype or family-history data for a carrier of this variant is available.
PP5 Not met Not met: no ClinVar expert-panel (3-star) pathogenic classification exists; the only submission is a 1-star laboratory 'Likely benign'.
clinvar
BA1 Not met Not met: the variant is absent (frequency 0) from gnomAD v2.1, v4.1, and gnomAD-Canada, so no population threshold is exceeded.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS1 Not met Not met: observed frequency is 0 in all three population databases, the opposite of a frequency greater than expected.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS2 Not met Not met: no healthy adult carriers or homozygotes are observed; the variant is absent from all three population databases.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS3 Not assessed Not assessed: no functional studies of this variant exist; in silico and population data cannot substitute for them.
spliceai clinvar oncokb PMID:25394175 vcep_path_250_323 generic_acmg_combination_rules
BS4 Not assessed Not assessed: no affected family member has been tested and reported as not carrying the variant.
clinvar PMID:25394175 generic_acmg_combination_rules final_classification_framework
BP1 N/A Not applicable: BP1 applies to missense variants, and this variant is synonymous (p.Ser988=).
pvs1_variant_assessment vcep_path_250_323 pvs1_gene_context PMID:25394175
BP2 Not assessed Not assessed: no genotype data exists to establish a trans or cis configuration with a pathogenic variant.
clinvar pm5_candidates generic_acmg_combination_rules final_classification_framework PMID:25394175
BP3 N/A Not applicable: the variant is a single-nucleotide substitution, not an in-frame indel in a repeat region.
generic_acmg_combination_rules final_classification_framework
BP4 Not met Not met: the only 'no impact' prediction (SpliceAI max delta 0.01) is already counted under BP7; no independent benign computational line exists.
spliceai vcep_path_250_323_s003 vcep_path_250_323_s004 final_classification_framework generic_acmg_combination_rules
BP5 Not assessed Not assessed: no reported carrier with an alternate molecular basis exists, so an alternate diagnosis can be neither established nor excluded.
BP6 Not met Not met: the 'Likely benign' label is a 1-star laboratory submission, not an expert-panel classification, so BP6 does not apply.
clinvar
BP7 Met Met (supporting): synonymous p.Ser988= with SpliceAI max delta 0.01, far below the 0.2 impact threshold, predicting no splice effect.
spliceai pvs1_variant_assessment generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.